MiR-291b-3p induces apoptosis in liver cell line NCTC1469 by reducing the level of RNA-binding protein HuR

Cellular Physiology and Biochemistry

Volumn 33, Issue 3, 2014, Pages 810-822

  Guo, Jun ^a,b   Li, Meng ^a,b   Meng, Xiangyu ^a,b   Sui, JingZhe ^b   Dou, Lin ^b   Tang, Weiqing ^b   Huang, Xiuqing ^b   Man, Yong ^b   Wang, Shu ^b   Li, Jian ^a,b  

^a PEKING UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Apoptosis; HuR, Bcl 2; miR 291b 3p; NCTC1469 cell

Indexed keywords

HUR PROTEIN; MICRORNA; MICRORNA 291B 3P; PROTEIN BAX; PROTEIN BCL 2; RNA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BCL2 PROTEIN, MOUSE; ELAV LIKE PROTEIN 1; ELAVL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FOLLOW UP; LIVER CELL; MALE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; DATA BASE; GENE EXPRESSION; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE TEST; LUCIFERASE ASSAY; PROTEIN TARGETING; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN STABILITY; PROTEIN SYNTHESIS;

ANIMALS; APOPTOSIS; CELL LINE; ELAV-LIKE PROTEIN 1; HEPATOCYTES; MALE; MICE; MICRORNAS; PROTEIN BIOSYNTHESIS; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 84897124021     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358654     Document Type: Article

References (47)

1. Milenkovic D, Deval C, Gouranton E, Landrier JF, Scalbert A, Morand C, Mazur A: Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS One 2012;7:e29837.
2. Rottiers V, Naar AM: MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 2012;13:239-250.
3. Hu JZ, Huang JH, Zeng L, Wang G, Cao M, Lu HB: Anti-Apoptotic Effect of MicroRNA-21 after Contusion Spinal Cord Injury in Rats. J Neurotrauma 2013;30:1349-1360.
4. Farhana L, Dawson MI, Murshed F, Das JK, Rishi AK, Fontana JA: Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. PLoS One 2013;8:e61015.
5. Sharma S, Verma S, Vasudevan M, Samanta S, Thakur JK, Kulshreshtha R: The interplay of HuR and miR-3134 in regulation of AU rich transcriptome. RNA Biol 2013;10: 1283-1290.
6. Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B: Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis. Int J Mol Sci 2013;14:10015-10041.
7. Sahlberg AS, Ruuska M, Granfors K, Penttinen MA: Altered Regulation of ELAVL1/HuR in HLA-B27-Expressing U937 Monocytic Cells. PLoS One 2013;8:e70377.
8. Barreau C, Paillard L, Osborne HB: AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005;33:7138-150.
9. Peng SS, Chen CY, Xu N, Shyu AB: RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998;17:3461-3470.
10. Rodriguez-Pascual F, Hausding M, Ihrig-Biedert I, Furneaux H, Levy AP, Forstermann U, Kleinert H: Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 2000;275:26040-26049.
11. Chen CY, Xu N, Shyu AB: Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol Cell Biol 2002;22:7268-7278.
12. Yaman I, Fernandez J, Sarkar B, Schneider RJ, Snider MD, Nagy LE, Hatzoglou M: Nutritional control of mRNA stability is mediated by a conserved AU-rich element that binds the cytoplasmic shuttling protein HuR. J Biol Chem 2002;277:41539-41546.
13. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M: HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 2000;20:760-769.
14. Zou T, Mazan-Mamczarz K, Rao JN, Liu L, Marasa BS, Zhang AH, Xiao L, Pullmann R, Gorospe M, Wang JY: Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem 2006;281:19387-19394.
15. Ishimaru D, Ramalingam S, Sengupta TK, Bandyopadhyay S, Dellis S, Tholanikunnel BG, Fernandes DJ, Spicer EK: Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol Cancer Res 2009;7:1354-1366.
16. Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH: Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012;31:5081-5089.
17. Kojima K, Fujita Y, Nozawa Y, Deguchi T, Ito M: MiR-34a attenuates paclitaxel-resistance of hormonerefractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate 2010;70:1501-1512.
18. Xu F, Zhang X, Lei Y, Liu X, Liu Z, Tong T, Wang W: Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J Cell Biochem 2010;111:727-734.
19. Al-Ahmadi W, Al-Ghamdi M, Al-Souhibani N, Khabar KS: miR-29a inhibition normalizes HuR overexpression and aberrant AU-rich mRNA stability in invasive cancer. J Pathol 2013;230:28-38.
20. Prislei S, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, Shahabi S, Scambia G, Ferlini C: MiR-200c and HuR in ovarian cancer. BMC Cancer 2013;13:72.
21. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M: miR-519 reduces cell proliferation by lowering RNAbinding protein HuR levels. Proc Natl Acad Sci 2008;105:20297-20302.
22. Dou L, Zhao T, Wang L, Huang X, Jiao J, Gao D, Zhang H, Shen T, Man Y, Wang S, Li J: miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. J Biol Chem 2013;288:22596-22606.
23. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, Cabo R, Gorospe M: miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 2010;9:1354-1359.
24. Minero VG, Khadjavi A, Costelli P, Baccino FM, Bonelli G: JNK activation is required for TNFalpha-induced apoptosis in human hepatocarcinoma cells. Int Immunopharmacol 2013;17:92-98.
25. Shuh M, Bohorquez H, Loss GE, Jr., Cohen AJ: Tumor Necrosis Factor-alpha: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury. Ochsner J 2013;13:119-130.
26. Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, Wang T, Zhao G: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol 2013;36:385-394.
27. Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang Q, Zhang Y, Wang R, Xue L, Wang S, Wu S, Peng Y, Yang Y: miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK. PLoS One 2013;8:e72390.
28. Absalon S, Kochanek DM, Raghavan V, Krichevsky AM: MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons. J Neurosci 2013;33:14645-14659.
29. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM, Volkert TL, Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R, Young RA: Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008;134:521-533.
30. Zheng GX, Ravi A, Calabrese JM, Medeiros LA, Kirak O, Dennis LM, Jaenisch R, Burge CB, Sharp PA: A latent pro-survival function for the mir-290-295 cluster in mouse embryonic stem cells. PLoS Genet 2011;7:e1002054.
31. Luningschror P, Stocker B, Kaltschmidt B, Kaltschmidt C: miR-290 cluster modulates pluripotency by repressing canonical NF-kappaB signaling. Stem Cells 2012;30:655-664.
32. Yi X, Zhou Y, Zheng W, Chambers SK: HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer. Aust N Z J Obstet Gynaecol 2009;49:93-98.
33. Zhu Z, Wang B, Bi J, Zhang C, Guo Y, Chu H, Liang X, Zhong C, Wang J: Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer. Tumour Biol 2013;34:2299-2308.
34. Hostetter C, Licata LA, Witkiewicz A, Costantino CL, Yeo CJ, Brody JR, Keen JC: Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. Cancer Biol Ther 2008;7:1496-1506.
35. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL: Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 2012;91:651-658.
36. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W: Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006;125:1111-1124.
37. Tominaga K, Srikantan S, Lee EK, Subaran SS, Martindale JL, Abdelmohsen K, Gorospe M: Competitive regulation of nucleolin expression by HuR and miR-494. Mol Cell Biol 2011;31:4219-4231.
38. Epis MR, Barker A, Giles KM, Beveridge DJ, Leedman PJ: The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J Biol Chem 2011;286:41442-41454.
39. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB: The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 1992;141:881-886.
40. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS: Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res 2009;37:3612-3624.
41. Kim GY, Lim SJ, Kim YW: Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Mod Pathol 2011;24:1336-1347.
42. Yuan Z, Sanders AJ, Ye L, Wang Y, Jiang WG: Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol Rep 2011;26:237-245.
43. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH: Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res 2003;63:4181-4187.
44. Talwar S, Jin J, Carroll B, Liu A, Gillespie MB, Palanisamy V: Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress. J Biol Chem 2011;286:32333-32343.
45. Kullmann M, Gopfert U, Siewe B, Hengst L: ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev 2002;16:3087-3099.
46. Abdelmohsen K, Lal A, Kim HH, Gorospe M: Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 2007;6:1288-1292.
47. Hardwick JM, Soane L: Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol 2013;5:pii: a008722. doi: 10.1101/cshperspect.a008722.